Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

NCT07492693 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT07492693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07492693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
Lead sponsor
Changhai Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
October 1, 2024
Completion date
August 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced thrombocytopenia (cit) in patients with gastrointestinal tumors